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a  b  s  t  r  a  c  t
Pertussis  is  a highly  infectious  respiratory  disease  that  has  been  on the  rise  in  many  countries  worldwide
over the past  several  years.  The  drivers  of this  increase  in  pertussis  incidence  remain  hotly  debated,
with  a central  and  long-standing  hypothesis  that  questions  the ability  of  vaccines  to  eliminate  pertussis
transmission  rather  than  simply  modulate  the severity  of  disease.  In this  paper,  we present  age-structured
case  notiﬁcation  data  from  all provinces  of  Thailand  between  1981  and  2014,  a period  during  which
vaccine  uptake  rose  substantially,  permitting  an  evaluation  of  the  transmission  impacts  of  vaccination.
Our  analyses  demonstrate  decreases  in  incidence  across  all ages  with  increased  vaccine  uptake  – an
observation  that is  at odds  with  pertussis  case  notiﬁcation  data  in a number  of  other  countries.  To  exploreertussis
athematical model
mmunity
whether  these  observations  are  consistent  with  a rise  in  herd  immunity  and  a  reduction  in bacterial
transmission,  we  analyze  an  age-structured  model  that incorporates  contrasting  hypotheses  concerning
the  immunological  and  transmission  consequences  of vaccines.  Our  results  lead  us to  conclude  that  the
most parsimonious  explanation  for the  combined  reduction  in incidence  and the  shift  to older  age  groups
in the  Thailand  data  is vaccine-induced  herd  immunity.
ublis©  2016  The  Authors.  P
. Introduction
Pertussis, or whooping cough, is a highly infectious respira-
ory disease that remains a major public health concern (Wood
nd McIntyre, 2008; Domenech de Celles et al., 2016). Despite
he initial success of pediatric vaccination programs, pertussis is
urrently responsible for an estimated 300,000 deaths per year
orldwide (Crowcroft and Pebody, 2006). In addition, it has under-
one a resurgence in many countries – including the United States
Rohani and Drake, 2011; Magpantay and Rohani, 2015) – despite
aintaining high levels of vaccine uptake (Wood and McIntyre,
008). While many plausible mechanisms driving these dynamics
as been proposed (Jackson and Rohani, 2014; Domenech de Celles
t al., 2016), the protective immunity elicited by both whole cell
wP) and acellular (aP) vaccines has long been questioned (Preston
nd Stanbridge, 1972; Blennow et al., 1988; Ausiello and Cassone,
014). The absence of a reliable serological marker for protection
∗ Corresponding author. Tel.: +1 4135972424.
E-mail address: jcb5@williams.edu (J.C. Blackwood).
ttp://dx.doi.org/10.1016/j.epidem.2016.02.001
755-4365/© 2016 The Authors. Published by Elsevier B.V. This is an open access article 
/).hed  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
has meant that much of the discussion regarding the consequences
of vaccination for immunity have focused on epidemiological pat-
terns (Lavine et al., 2011).
The ability of whole cell vaccines to prevent pertussis trans-
mission has been discussed for more than ﬁfty year (Preston, 1965)
and was famously called into question by Fine and Clarkson (1982),
who argued based on patterns of periodicity in pertussis incidence
that whole cell vaccines likely prevented disease rather than trans-
mission. If true, this would lead to signiﬁcant silent circulation of
pertussis (Águas et al., 2006; Kretzschmar et al., 2010), posing a
major threat to unvaccinated or partially immunized infants, who
are at highest risk of pertussis-related complications and death.
More recently, the debate regarding the mechanisms behind per-
tussis resurgence and the potential role played by has centered
on acellular vaccines (Aoyama et al., 1985; Ausiello and Cassone,
2014; Domenech de Celles et al., 2014). Two  modeling studies have
concluded that pertussis resurgence may  be the natural conse-
quence of widespread switch to the aP vaccine (Gambhir et al.,
2015) and its inability to generate protective immunity (Edwards,
2014; Althouse and Scarpino, 2015). This conclusion is supported
by animal transmission models, in baboons (Warfel et al., 2014) and
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ice (Smallridge et al., 2014), where the experimental challenge of
P-vaccinated animals indicates the potential for a transmissible
nfection.
To better understand the extent of the cross-over between
ndividual-level animal challenge experiments to population-level
ertussis incidence in humans and the consistency between
pidemiological evidence in different countries, we examined
ncidence reports from Thailand. Speciﬁcally, we scrutinized age-
tratiﬁed incidence data from different provinces in Thailand from
981 to 2000. During this period, vaccine uptake systematically
ncreased from ∼26% in the early 1980s to greater than 95% by
id-1990s. We  explored the epidemiological consequences of this
accine ramp-up to assess the protective effects of wP vaccination.
e paid particular attention to changes in incidence among “high
isk” groups – such as unvaccinated infants – as uptake increased.
pidemiological theory predicts that vaccination programs that
uccessfully protect vaccinees from infection should induce herd
mmunity, thereby minimizing transmission to unprotected high
isk groups (Gay and Miller, 2000). Tracking incidence in these
ge-groups is therefore an essential component to quantifying the
uccess of vaccination in reducing circulation (Keeling and Rohani,
008; Domenech de Celles et al., 2016). For this reason, we also
xamined pertussis incidence reports from 2003 to 2014 in infants
ounger one month and those between 1 and 12 months.
The analyses of age-incidence patterns were allied to two  age-
tructured transmission models, which were used to distinguish
mong competing hypotheses about the role of vaccine-protection
s a driver of observed age-structured incidence (ex. Riolo et al.,
013; Lavine et al., 2011; Rohani et al., 2010). We  challenged
hese models to capture the qualitative epidemiological transition
bserved in Thailand when contrasting assumptions were made
egarding the immunological impacts of infant immunization. In
revious analyses, we reported that there is an increase in herd
mmunity with vaccine uptake in Thailand and we supported these
laims through the use of statistical inference to select a best-ﬁtting
odel of pertussis dynamics (Blackwood et al., 2013). However,
hat analysis primarily considered the aggregate data independent
f age. Here, we provide additional corroboration via a study of
ge-structured dynamics. Consistent with our prior analyses, we
nd empirical support for increased herd immunity with vaccine
ptake in Thailand, a ﬁnding that is re-inforced by our transmission
odeling.
. Pertussis incidence data, 1981–2000
Thailand adopted the National Expanded Programme on Immu-
ization (EPI) in 1977 for infant vaccination. Initially, two doses
f the diptheria–tetanus–pertussis (DTP) whole cell vaccine was
dministered until a third dose was added to the schedule in 1982
Bhunbhu, 1989). Beginning in 1992, the schedule included 5 doses
f DTP at 2, 4, 6, and 18 months with the ﬁnal booster dose at 4–6
ears. The whole cell vaccine was used exclusively until 1998. Since
hen, the DTP-HiB has been favored in government clinics and the
cellular vaccine (DTaP) in private clinics. We  obtained the corre-
ponding annual national vaccine uptake estimates for 1981–1996
nd 1999 from the Vaccine Coverage Survey of Thailand. Missing
ears (1997–1998, 2000) were assumed to have attained the same
ptake as the most recently reported year.
Annual case notiﬁcation data from each of Thailand’s 72
rovinces between 1981 and 2000 were obtained from the Min-
stry of Public Health (Bureau of Epidemiology, 1981–2000). From
981 to 2000, the case notiﬁcation data were also available annually
or the following age groups: under 1 year, 1–4, 5–9, 10–14, 15–24,
5–34, 35–44, 45–54, 55–64, and older than 65 years of age. In 1985
hese data were also available for one-year age groups up to agemics 16 (2016) 1–7
seven. In our analysis we assumed the age of cases were uniformly
distributed between all ages within each age group. We  obtained
age-stratiﬁed population data for 1980, 1990, and 2000 from the
National Statistical Ofﬁce of Thailand censuses and log-linear ﬁts
between census years were used to estimate annual population
sizes from 1981 to 2000 (National Statistical Ofﬁce of Thailand,
1980, 1991, 2001).
3. Age-structured incidence dynamics
In this section, we  present the age-structured incidence data
from Thailand during the time period 1981–2000. To paint a general
picture of pertussis in Thailand, in Fig. 1A we  present aggregated
monthly incidence in addition to the annual vaccine uptake. Three
clear epidemics are observed in 1981, 1982, and 1983 followed
by a rapid decline from 1984 to 1990 and stable low incidence
throughout the 1990s. These dynamics coincide with the rapid rise
in vaccine uptake, which consistently exceeds 95% beginning in
1996.
Fig. 1A also includes two  shaded regions: 1981–1983 (gray) and
1996–2000 (green). These two time periods display dramatically
different incidence patterns corresponding to changes in vaccine
uptake. Namely, incidence was  highest from 1981 to 1993 when
vaccine uptake was  the lowest, and incidence remained very low
from 1996 to 2000 when vaccine uptake remained above 95%. A
comparison of the age-speciﬁc incidence patterns during these two
“eras” is presented in Fig. 1B, depicting the percentage of reported
cases attributed to ﬁve different age groups (under 1 year, 1–4, 5–9,
10–15, and 15+ years). The ﬁgure indicates a shift in incidence to
older age groups in the later era.
To observe the age-stratiﬁed dynamics at a ﬁner temporal reso-
lution, in Fig. 1C we display the percentage of annual cases in four
age classes. During the early through mid-1980s, the age distribu-
tion of cases remains relatively stable with between 13% and 23%
of all cases attributed to infants. The percent of cases in infants
then rises brieﬂy and drops again in the early 1990s. The decline in
the percent of cases in infants coincides with a dramatic increase
in vaccine uptake. While this is indicative of reduced transmis-
sion to infants – who are more susceptible to disease because
they are less likely to be fully immunized against pertussis – it
should be noted that the incidence is very low throughout the
1990s. As a consequence, variability in the age-distribution is to
be expected and such variation is indeed observed during the years
post-1995.
To determine whether these observations are consistent at
ﬁner spatial resolutions, Fig. 2B–G replicates Fig. 1B for each of
the six distinct geographic regions of Thailand (as developed by
the National Geographical Committee in 1978). In Fig. 2B–G, the
percent of cases in each age group from 1981 through 1983 are rep-
resented by gray bars and the percent of cases in each age group
from 1996 to 2000 are in color. The bars are colored by region, and
Fig. 2A provides a map  of Thailand such that the provinces in each
region are colored accordingly. These data are consistent with those
for Thailand as a whole (Fig. 1B), with a higher percentage of cases
attributed to older age classes during 1996–2000. While the West-
ern (Fig. 2C, pink) region appears to contradict this observation, it
only accounts for 5.3% of the total cases in Thailand and therefore
has minimal impact on the overall age-structured dynamics in the
country as a whole.
Previous work has shown that an increase in the mean age of
infection may  correspond to decreasing transmission to infants
(e.g. Skowronski et al., 2002). We therefore estimated the mean
age of infection for the early (1981–1983) and late (1996–2000)
vaccine eras, assuming that cases are uniformly distributed within
age classes (see Supplementary information for details). To test
J.C. Blackwood et al. / Epidemics 16 (2016) 1–7 3
Fig. 1. (A) Monthly incidence in Thailand (black) and the corresponding vaccine uptake (red) from 1981 through 2000. These colors match the data as shown in (B) of this
ﬁgure. (B) The percent of cases in ﬁve different age groups during the time period 1981–1983 (gray bars) compared to the time period 1996–2000 (green bars). Note that
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dolescents and adults. (C) Percent of annual cases per year in four different age g
ases  in individuals ages 5+ tends to increase for the remainder of the time series.
hether the mean age at infection signiﬁcantly increased from
he early to the late era, we bootstrapped the ages of the case
eports. The resulting distribution of 10,000 bootstrap samples for
ach region revealed a signiﬁcant increase of 4.31, 2.07, 1.93, and
.87 years, respectively, for Regions 3–6. With the exception of
egion 5, the respective 95% CI for each vaccine era were completely
on-overlapping. In contrast, there was no increase in the mean
ges of infection in Regions 1 and 2 (details and ﬁgures provided
n Supplementary information). However, we note that Regions 1
nd 2 account for only 15% of the total cases reported in Thailand.
or the purposes of comparison, we performed the same analysis
n the aggregated data at the national level. We  estimated that
he nationwide mean age of infection increased from 5.44 years
n 1981–1983 to 7.77 years in 1996–2000. The resulting distribu-
ion of 10,000 bootstrap samples displays a shift in the mean age
f infection between the vaccine eras (Fig. 4B). In fact, the 95% CIs
re completely non-overlapping ((5.35, 5.52) years for the ﬁrst vac-
ine era and (7.12, 8.65) for the later era). Therefore, there is a clear
ncrease in the mean age of infection that is driven by the incidence
ynamics in Regions 1–4.
Finally, an alternative way to visualize the impact of vacci-
ation on age-structured incidence is presented in Fig. 4A. Here,
he age-speciﬁc incidence is shown when vaccine uptake is rel-
tively low (<46%, in red) as well as when it is high (>95%, in
lue). This ﬁgure displays the average of the aggregate incidence
cross Thailand for each vaccine era. Under the assumption thats, the distribution of cases shifts so that there is a greater percentage of cases in
. The age distribution stays relatively constant until 1988 and then the percent of
case reports were drawn from a binomial distribution, 95% CIs are
found using the Fisher information. Here, the increase in vaccine
uptake clearly corresponds to a decline incidence across all ages,
especially in infants. In particular, there were an average of 571
cases in infants per year during 1981–1983 compared to an average
of 13.2 cases per year during 1996–2000. While these averages are
computed at the national level, we  demonstrate that the decrease
in cases in infants is consistent across the provinces of Thailand
(see Supplementary information). Fig. 4A is consistent with declin-
ing pertussis transmission following vaccination. We  assume that
reporting is consistent across all ages, so while biases in reporting
may  contribute to the dynamics, we argue that it is very unlikely
that reporting alone accounts for the observed dramatic shift in age
structure.
4. Modeling age-structured pertussis dynamics
While the age stratiﬁed incidence data are strongly suggestive
of decreased transmission with increased vaccination, they do not
eliminate the possibility that vaccines prevent symptomatic dis-
ease but not transmission (Fine and Clarkson, 1982; Águas et al.,
2006). Ideally, this issue would be resolved by statistical infer-
ence methods applied to a mechanistic transmission model (e.g.,
Blackwood et al., 2013; Gambhir et al., 2015). However, the absence
of age-stratiﬁed data more highly resolved than annual incidence
precludes such an analysis. We therefore formulated a simple
4 J.C. Blackwood et al. / Epidemics 16 (2016) 1–7
Fig. 2. The percent of cases in age group from 1981 to 1983 (light gray bars) as compared to the percent of cases in each age group from 1996–2000 (colored bars). The color
representing 1996–2000 in (B)–(G) correspond to one of the six distinct geographic regions of Thailand: (B) Northern, (C) Western, (D) Central, (E) Northeastern, (F) Eastern,
and  (G) Southern region. (A) provides a map  of Thailand that is colored according to region. With the exception of the Western region (which only accounts for 5.3% of the
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total  cases in Thailand), the percentage of cases in older age groups increases in all 
ge-structured mathematical model (Rohani et al., 2010) for use
s a heuristic device: to explore the dynamical consequences of
lternative assumptions regarding vaccine impact and their parsi-
ony with the Thai data. For the purposes of direct comparison
ith the Thai data (Fig. 4A), we explored ﬁve age classes: <1, 1–4,
–9, 10–14, and >15 years old.
Our compartmental transmission models were constructed
sing the SIR (susceptible–infected–recovered) paradigm
Anderson and May, 1991; Keeling and Rohani, 2008). Con-
istent with estimates obtained via likelihood-based statistical
nference of the Thai data (Blackwood et al., 2013), we  assumed
aturally acquired immunity to be lifelong. We  assumed newborns
<1 year) to be susceptible to pertussis. Upon entering the next age
lass, with probability p, an infant may  be immunized. In the ﬁrst
odel, we assumed that both immunization and naturally acquired
nfections provide lifelong protection against pertussis infection,
ielding a simple SIR model. In the second model, we assumed that
nly naturally acquired infections results in lifelong immunity. To
xamine the consequences of vaccine-induced protection against
nfection versus disease, we assumed immunization to provide
 temporary period of protection against infection after which
ndividuals experience reduced susceptibility to disease, but not
nfection. Speciﬁcally, this model included three additional classes:
 vaccinated and fully protected class V (with mean duration of
rotection 1/  years), a vaccinated but susceptible to infection class
V, and a vaccinated infected class (IV) in which individuals were
ssumed to be asymptomatic but otherwise function identically to
nfectious individuals with no history of vaccination. In this model,
nly symptomatic infections (I individuals) were reported which
llowed us to directly examine whether subclinical infections can
xplain the shift in the age structure of case notiﬁcations. We  refer
o this model as SIVIR.s in the later time period.
For all age classes and both models, the force of infection – the
per capita hazard of transmission experienced by susceptibles – due
to individuals in the infected (I) class is
i =
5∑
j=1
ˇijIj, (1)
where ˇij represents the transmission rate from individuals in the
jth age class to members of the ith age class, and Ii is the proportion
of the population infected in each age group i, as speciﬁed above.
The SIVIR additionally had an associated force of infection arising
from individuals in the infected class that can transmit without
being observed. We  denoted this by V
i
:
Vi =
5∑
j=2
ˇVij I
V
j , (2)
where IV
j
is the proportion of individuals who are infected but were
previously vaccinated in each age group j.
To analyze the SIR and SIVIR models, we  assumed two con-
trasting patterns of age-speciﬁc contacts: (i) homogeneous mixing
and (ii) age-assortative contact structure, as reported from the
POLYMOD study of several European countries (Mossong et al.,
2008). The results for the two  different assumptions on contact
structure were similar, so the results using the POLYMOD con-
tact matrix are presented in Supplementary information. The basic
reproduction ratio, R0, set to equal 16 in both models. The models
were simulated for levels of vaccine uptake ranging from 46% to
95%, as observed in Thailand. To quantify the age-stratiﬁcation of
transmission, we obtained the equilibrium prevalence in each age
class (i.e., I∗
i
/ni, where ni is the proportion of the population in age
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(ig. 3. Schematic representation of the age-structured models: the SIR model is the
chematic on the upper panel and the SIVIR model is on the lower panel. Full model
escriptions are provided in Supplementary information.
lass i). A schematic of each model is provided in Fig. 3 and the
odels are fully described in Supplementary information.
The age distribution of incidence predicted from the SIR model
nd the SIVIR model are displayed in Fig. 4C. The observed changes
n the Thailand data were well-captured by the SIR model (dashed
ines) with a incidence dramatically reduced across all age classes
hen vaccine uptake is increased to 95%. In contrast, under the
ssumption that vaccine prevents disease but not transmission (the
IVIR model), incidence is lowered in older age groups but remains
igh in unvaccinated infants.
ig. 4. (A) Mean age structure of aggregated annual case notiﬁcations in Thailand with vac
996–2000, blue). Under the assumption that case reports are drawn from a binomial dist
f  10,000 bootstrap samples of the mean age of infection (p< 46 % in gray, p> 95 % in green)
nd  (7.12, 8.65). Results from the SIVIR model assuming homogeneous mixing are displaye
he  total population in age group i. Prevalence is corrected to account for the difference b
re  reported monthly. This is shown for various levels of vaccine uptake while holding th
alues  1/ while holding vaccine uptake at 95% (left side of colormap circle). The dashed
blue)  vaccine uptake.mics 16 (2016) 1–7 5
To determine the sensitivity of the dynamics of the SIVIR model
to vaccine uptake, we ran the model for several vaccine uptake
levels. As shown in Fig. 4C, incidence in all age classes decreased as
vaccine uptake increased, except incidence in the infant class which
remains unchanged. To determine whether a longer duration of
temporary immunity following vaccination can qualitatively pro-
duce changes in age incidence consistent with the observed case
notiﬁcation data, we also varied the number of years spent in the
protected vaccinated class (1/) while holding vaccine uptake at
95% (indicated by blue on the colormap). While a long duration
of immunity (up to 1/  = 100 years) yields lower levels of inci-
dence among infants, these reductions do not achieve comparable
levels of the decline observed in data. This qualitative analysis
is consistent with the interpretation that vaccination effectively
reduces pertussis transmission (Blackwood et al., 2013), with the
SIR model providing the most parsimonious explanation of the data.
The details of age-speciﬁc patterns of contacts did not affect our
qualitative conclusions.
5. Contemporary pertussis incidence: 2003–2014
Our analyses of incidence data from 1981 to 2000 support the
conclusion that vaccination in Thailand has reduced the trans-
mission of pertussis. However, in many countries, a honeymoon
effect has been observed whereby the initial impact of high vac-
cine coverage has been to markedly reduce incidence only for a
rebound at a later date (McLean and Anderson, 1988; Rohani and
Drake, 2011; Riolo et al., 2013; Magpantay et al., 2014; Magpantay
cine uptake of <46% (years 1981–1983, red) and high vaccine uptake of >95% (years
ribution, shading indicates 95% CI using the Fisher information. (B) The distribution
. The sample means are 5.44 and 7.77 years, respectively with 95% CI of (5.35, 5.52)
d in (C) as the equilibrium prevalence by age group, I∗
i
/ni , where ni is the fraction of
etween the modeled infectious period (21 d) versus actual case notiﬁcations which
e duration of immunity 1/ at one year (right side of colormap circle) and various
 lines display the results from the age-structured SIR model for low (red) and high
6 J.C. Blackwood et al. / Epidemics 16 (2016) 1–7
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he  Fisher information. (A) Incidence in infants <28 d, (B) is 28 d – 1 year, and (C) is t
hat  fall farthest from the mean across all age groups in each year.
nd Rohani, 2015). To examine the contemporary transmission of
ertussis in Thailand, we depict, in Fig. 5, age-stratiﬁed pertussis
ncidence from 2003 to 2014. These data indicate that pertussis
ncidence remains very low, at levels comparable to those displayed
n Fig. 4A corresponding to vaccine uptake >95%. The contemporary
ata are especially informative regarding transmission dynamics
ince they include incidence among infants <28 days old, who  are
oo young to be immunized. Hence, any resurgence in pertussis
ransmission would be expected to result in an increasing trend
n incidence among this age group. Indeed, incidence remains very
ow and in half of the years from 2002 to 2014 there are no reported
ases in this age class. We  submit that the absence of any rising
rend, together with the rarity of pertussis in young infants, may
e taken as additional support for vaccine-induced herd immunity
n Thailand.
. Discussion
Pertussis incidence has continued to rise over the last couple
f decades in many developed countries in spite of longstanding
accination programs, some of which began as early as the 1940s
Bass and Stephenson, 1987; Güris¸ et al., 1999). Understanding the
rivers of this resurgence is becoming increasingly critical as case
eports continue to rise. For example, in 2012 the United States
ad 48,277 cases reported to the World Health Organization – the
ost cases in a given year since 1959 and substantially higher than
he number of cases reported in the epidemic of 2010 (27,550)
Clark, 2014; World Health Organization, 2014). A central question
hat has persisted for more than three decades concerns the trans-
ission consequences of vaccines, and speciﬁcally whether they
erely protect against disease and not infection. These differences
ave signiﬁcant impacts on the design of successful booster vacci-
ation programs (Rohani et al., 2015). In this paper, we returned to
his issue by taking advantage of long-term age-stratiﬁed pertus-
is incidence records in Thailand allied to contrasting hypotheses
egarding vaccine impacts formulated within mathematical trans-
ission models.
Much of the recent pertussis vaccines literature has focused
n the role of the acellular vaccines (DTaP) (Aoyama et al., 1985;
usiello and Cassone, 2014; Domenech de Celles et al., 2014; Warfel
t al., 2014; Smallridge et al., 2014). In contrast, in Thailand these reports are drawn from a binomial distribution, shading indicates 95% CI using
an incidence across all older age groups. In (C), 95% CIs are displayed as the bounds
whole cell vaccine (DTwP) was  exclusively used until 1998 after
which a combination of the acellular and whole cell vaccines have
been in use. Our examination of age-structured case notiﬁcation
data from different regions of Thailand over the period 1981–2000
indicated a substantial decrease in incidence as vaccine uptake
increased. Although much of these data correspond to the period
in which DTwP was  the only vaccine used (1981–1998), incidence
remained very low in Thailand from 2003 to 2014 – with only 14
cases reported in 2014.
While the data appear to paint a clear picture of a rise in herd
immunity, it is plausible that alternative mechanisms may yield
a similar age-speciﬁc proﬁle of cases. If vaccination simply pre-
vents clinical symptoms rather than transmission, the decrease
in incidence could be the natural result of a greater number
of undiagnosed asymptomatic cases. To parse these alternatives,
we analyzed two age-structured transmission models. The ﬁrst
model assumed that vaccination protects from infection (the age-
structured SIR model) whereas the second, and more complex,
model assumed that following temporary vaccine-derived immu-
nity, individuals can acquire an asymptomatic infection that goes
unreported (the SIVIR model). The resulting age distribution of inci-
dence in each of these models is found for both high and low levels
of vaccine uptake and compared to the corresponding age-structure
of the data. While the SIVIR model accurately captured lowered inci-
dence in older age groups following high levels of vaccine uptake,
it failed to capture the substantial decline in incidence in infants
as observed in the data. In contrast, the simple age-structured SIR
model accurately predicted substantially lowered incidence across
all age groups, including infants. To assess the robustness of our
conclusions, we determined the sensitivity to the SIVIR model to
various levels of vaccine uptake ranging from 46% to 95%. Fur-
ther, we  allowed the duration of temporary immunity provided by
vaccination to range from one to 100 years. While increasing the
duration of temporary immunity caused a decrease in incidence
in infants with high levels of vaccine uptake, all parameter values
failed to reproduce the dramatic decline in incidence in infants as
observed in the data. Further, this analysis was performed for both
homogeneous mixing of contacts and non-homogeneous mixing;
both analyses yielded qualitatively similar results.
Through combining age-structured incidence data and math-
ematical models, our ﬁndings point to a rise in herd immunity
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s a result of a decline in transmission following vaccination in
hailand. We  submit that these ﬁndings provide a useful coun-
erpoint to the increasing reliance on serology. For instance,
anlapakorn et al. (2016) have recently presented age-stratiﬁed
erological data from Thailand indicating declining antibody levels
ith age. Despite the uncertainty associated with the interpreta-
ion of pertussis toxin antibodies as a correlate of protection, the
uthors recommend “a booster dose during adolescence should
e considered in order to reduce the incidence of pertussis dis-
ase”. Our examination of pertussis incidence reports lead us to
uestion this inference. Substantial pertussis circulation among
dults and adolescents would inevitably lead to increased incidence
mong infants, especially those too young to be immunized (Gay
nd Miller, 2000; Domenech de Celles et al., 2016). In contrast, the
ery low incidence in infants in high-vaccine coverage periods is a
trong indicator of herd immunity.
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